Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Clinical Pharmacokinetics
|
August 21, 2001
Pegylation: a novel process for modifying pharmacokinetics
J M Harris, N E Martin, M Modi
Pediatric Research
|
September 1, 1993
Oxidant stress responses in premature infants during exposure to hyperoxia
C V Smith, T N Hansen, N E Martin, et al.
International Journal of Clinical Practice
|
May 23, 2013
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
V W Nitti, V Khullar, P van Kerrebroeck, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
May 6, 2017
A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer
N N Sanford, P J Catalano, P C Enzinger, et al.
Prostate Cancer and Prostatic Diseases
|
January 25, 2017
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
P L Nguyen, N E Martin, V Choeurng, et al.
Physics in Medicine and Biology
|
July 7, 2021
Improvements in beam's eye view fiducial tracking using a novel multilayer imager
T C Harris, J Seco, D Ferguson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2014
Incidence and determinants of 1-month mortality after cancer-directed surgery
B A Mahal, G Inverso, A A Aizer, et al.
Prostate Cancer and Prostatic Diseases
|
July 2, 2014
The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act
B A Mahal, A A Aizer, D R Ziehr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
B A Mahal, Y-W Chen, V Muralidhar, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Clinical Pharmacokinetics
|
August 21, 2001
Pegylation: a novel process for modifying pharmacokinetics
J M Harris, N E Martin, M Modi
Pediatric Research
|
September 1, 1993
Oxidant stress responses in premature infants during exposure to hyperoxia
C V Smith, T N Hansen, N E Martin, et al.
International Journal of Clinical Practice
|
May 23, 2013
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
V W Nitti, V Khullar, P van Kerrebroeck, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
May 6, 2017
A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer
N N Sanford, P J Catalano, P C Enzinger, et al.
Prostate Cancer and Prostatic Diseases
|
January 25, 2017
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
P L Nguyen, N E Martin, V Choeurng, et al.
Physics in Medicine and Biology
|
July 7, 2021
Improvements in beam's eye view fiducial tracking using a novel multilayer imager
T C Harris, J Seco, D Ferguson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2014
Incidence and determinants of 1-month mortality after cancer-directed surgery
B A Mahal, G Inverso, A A Aizer, et al.
Prostate Cancer and Prostatic Diseases
|
July 2, 2014
The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act
B A Mahal, A A Aizer, D R Ziehr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
B A Mahal, Y-W Chen, V Muralidhar, et al.
Page
of 1